JVJose Javier Arenas Villafranca

Jose Javier Arenas Villafranca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jose Javier Arenas Villafranca has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    QR code–enabled self-access lifestyle education in older people living with HIV: a pragmatic pilot implementation study. (Preprint)

    by Yamal Jamal-Ismail, Santiago Vico, Javier Pérez-Stachowski, Jimena Abilés, Pedro Alarcón, Javier Arenas-Villafranca, Francisco Rivas-Ruiz, Alfonso Del Arco, María Dolores Martín-Escalante, Julián Olalla


  • Open Access

    Six-month outcomes of a QR Code–Enabled, self-access lifestyle education program to address frailty in older Adults Living With HIV: A prospective single-arm study: A quasi-experimental pre-post study. (Preprint)

    by Yamal Jamal-Ismail, Santiago Vico, Javier Pérez-Stachowski, Jimena Abilés, Pedro Alarcón, Javier Arenas-Villafranca, Francisco Rivas-Ruiz, Alfonso Del Arco, María Dolores Martín-Escalante, Julián Olalla

    BACKGROUND Frailty is prevalent and dynamic among older people living with HIV (PLWH), and it is associated with adverse outcomes. Lifestyle interventions (diet and physical activity) are recommended, but implementation is limited by resources and patient-level barriers. Digital, self-access education may help scale lifestyle support, yet its effectiveness and limitations in older, multimorbid populations remain uncertain. OBJECTIVE To evaluate 6-month changes in frailty phenotype status and related clinical, behavioral, and psychosocial outcomes after a QR code–enabled, self-access lifestyle education program (Mediterranean diet and exercise routines) delivered to PLWH aged ≥60 years. METHODS We conducted a prospective, quasi-experimental, uncontrolled before-and-after study (single-group pre–post design) with a 6-month follow-up in the HIV outpatient clinic of Universitary Hospital Costa del Sol (Marbella, Spain). Participants received a tri-fold leaflet containing QR codes linking to curated YouTube videos with guidance on Mediterranean diet and aerobic/resistance exercise (basic and advanced levels), as an adjunct to usual clinical care. Frailty was assessed using Fried’s Frailty Phenotype (robust, prefrail, frail). Secondary outcomes included changes in individual frailty criteria and patient-reported measures (insomnia severity [ISI], resilience [CD-RISC-10], loneliness [UCLA], anxiety/depression [HADS]), physical activity (IPAQ), Mediterranean diet adherence (The Andalusian Regional Government Mediterranean Diet Adherence Questionnaire), and inflammatory/immunologic markers (eg, IL-6, hsCRP, D-dimer, CD4/CD8 ratio). We described transitions between frailty states and compared baseline vs 6-month values using paired tests: McNemar’s test was used for categorical variables and the paired Student’s t test was used for continuous variables (Wilcoxon signed-rank test in case of non-normal distribution). RESULTS Of 52 enrolled participants at baseline, 50 were included in the 6-month analysis (available-case). Frailty status showed frequent transitions between adjacent states with no direct robust↔frail transitions. Half of frail participants improved to prefrail (2/4), while 20% of prefrail participants improved to robust (5/25). Conversely, 47.6% of robust participants transitioned to prefrail (10/21), and 24% of prefrail participants transitioned to frail (6/25). No statistically significant changes were observed in inflammatory/immunologic markers or physical activity/diet adherence. Insomnia severity improved (ISI median 6.5 to 4; P=.001) and resilience increased (CD-RISC-10 median 32 to 37; P<.001), while loneliness worsened (UCLA median 34.5 to 38; P=.001). Grip strength did not improve among those impaired at baseline. CONCLUSIONS In older PLWH, a QR code–enabled, self-access lifestyle education program was associated with meaningful improvements in insomnia and resilience but did not produce detectable short-term changes in inflammation, physical activity, diet adherence, or grip strength, and loneliness worsened. Frailty remained highly dynamic with bidirectional transitions, supporting the need for multi-component programs that combine scalable digital education with strategies to enhance engagement, resistance training uptake, and social connectedness. CLINICALTRIAL Not applicable.

  • El problema de la isoapariencia de medicamentos en España: es hora de actuar

    by J.A. Montero Delgado, S. Plata Paniagua, J.J. Arenas Villafranca


  • Systematic review of drug bioavailability following gastrointestinal surgery

    by Manuela Moreno Santamaría, José Javier Arenas Villafranca, Jimena Abilés, Alberto Fernández López, Lucia Visiedo Rodas, Begoña Tortajada Goitia, Pilar Utrilla Navarro

    Inter- and intraindividual pharmacokinetics variability in humans affects the way in which drugs act on the body. Gastrointestinal surgery has an impact on this variability and significantly alters the kinetics of drugs in post-surgical patients. The way in which pharmacokinetic profiles are modified depends on the type of operative procedure performed. The extent to which the absorption of different groups of drugs is affected varies according to the site and length of intestinal resections.


  • An admission medication reconciliation programme carried out by pharmacists: impact on surgeons' prescriptions

    by José Javier Arenas-Villafranca, Manuela Moreno-Santamaría, Carmen López Gómez, Isabel Muñoz Gómez-Millán, Elena Álvaro Sanz, Begoña Tortajada-Goitia

    Objectives To describe a medication reconciliation (MR) procedure prepared by the pharmacist for patients admitted for elective surgery and to assess the surgeon’s degree of acceptance. Methods A 1-year retrospective observational study was conducted. The patient population consisted of patients aged ≥18 years admitted during 2016 for elective surgery and whose planned length of hospital stay was >24 hours. A pharmacist performed MR following a specific protocol. A review of the reconciliations prescribed later by the surgeons was conducted. Statistical analyses were performed for qualitative and quantitative variables. Results The pharmacist prepared a total of 1986 reconciliation reports. The 179 patients reviewed in this study had a mean age of 65.7±11.8 years, 49.2% were women and 98.9% of patients were reconciled by the surgeon in the operating theatre using an electronic prescribing system (85.5% were fully reconciled). Conclusion The hospital’s MR protocol resulted in almost 100% of patients being reconciled within the subgroup of elective surgery patients by the prescribing surgeons.

  • The role of clinical pharmacists in the optimisation of medication prescription and reconciliation on admission in an emergency department

    by José Javier Arenas-Villafranca, Juan Manuel Rodríguez-Camacho, María Antonia Pérez-Moreno, Manuela Moreno-Santamaría, Francisco de Asís Martos-Pérez, Begoña Tortajada-Goitia

    Objectives To describe a clinical pharmacist’s (CP) activity in an emergency department (ED) regarding medication reconciliation and optimisation of pharmacotherapy of patients at hospital admission. Methods A 1-year prospective observational study was conducted to analyse the activity of a CP in the ED of a 350-bed hospital in Spain. The CP reviewed home medications and medical prescriptions of patients to perform medication reconciliation if required and intervene if medication errors were detected. Results The CP reviewed medications and medical orders of 1048 patients. 816 patients had home medication: 440 patients (53.9%) were correctly reconciled by the physician; 136 (16.7%) were reconciled by the physician with unintentional discrepancies; and 240 (29.4%) by the CP, with a higher percentage in patients admitted to surgical departments (χ2:38.698; P<0.001). Following pharmaceutical validation, 434 pharmaceutical interventions were performed. Conclusions The presence of a CP in an ED could increase the detection of reconciliation errors and help resolve medication errors.


  • Open Access

    Effects of cyclic parenteral nutrition on parenteral-associated liver dysfunction parameters

    by Jose J. Arenas Villafranca, Miriam Nieto Guindo, Elena Álvaro Sanz, Manuela Moreno Santamaria, Marga Garrido Siles, Jimena Abilés

    Introduction One of the most common complications of parenteral nutrition (PN) is liver dysfunction (LD). Therapeutic approaches for LD include, among others, administering cyclic parenteral nutrition (cPN), allowing some hours for metabolic rest. The purpose of this study was to evaluate the effectiveness of cPN in treating PN-associated LD. Materials and methods A retrospective observational study was carried out at the Costa del Sol Hospital in Spain between 2013 and 2014. The study involved inpatients ≥18 years old prescribed with cPN due to the development of PN-associated LD. The hepatic biochemical parameters measured at baseline and after completion of cPN included aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltransferase (GGT), alkaline phosphatase (ALP) and total bilirubin (TB). Quantitative values (age, biochemical parameters) were compared using matched Student’s t-test; the mean change in qualitative variables (sex, indication of PN, hepatic comorbidities, presence of insulin in cPN, infection during cPN, management of LD prior to cPN administrarion) was estimated using Mann-Whitney U test, and bivariate correlation between quantitative variables was determined by Spearman’s coefficient of correlation. Results Thirty-seven patients met inclusion criteria. All hepatic function parameters except ALP improved after the administration of cPN, with statistically significant differences (p < 0.05) in AST GGT and TB. Conclusion cPN improves PN-associated LD by restoring abnormal AST, GGT, and BT levels to normal, and reducing ALT levels close to normal. The results obtained suggest that the administration of cPN is effective in reverting PN-associated LD.


  • Open Access

    Protocol for the detection and nutritional management of high-output stomas

    by Jose J Arenas Villafranca, Cristobal López-Rodríguez, Jimena Abilés, Robin Rivera, Norberto Gándara Adán, Pilar Utrilla Navarro

    An issue of recent research interest is excessive stoma output and its relation to electrolyte abnormalities. Some studies have identified this as a precursor of dehydration and renal dysfunction. A prospective study was performed of the complications associated with high-output stomas, to identify their causes, consequences and management. This study was carried out by a multidisciplinary team of surgeons, gastroenterologists, nutritionists and hospital pharmacists. High-output stoma (HOS) was defined as output ≥1500 ml for two consecutive days. The subjects included in the study population, 43 patients with a new permanent or temporary stoma, were classified according to the time of HOS onset as early HOS (<3 weeks after initial surgery) or late HOS (≥3 weeks after surgery). Circumstances permitting, a specific protocol for response to HOS was applied. Each patient was followed up until the fourth month after surgery. Early HOS was observed in 7 (16 %) of the sample population of 43 hospital patients, and late HOS, in 6 of the 37 (16 %) non-early HOS population. By type of stoma, nearly all HOS cases affected ileostomy, rather than colostomy, patients. The patients with early HOS remained in hospital for 18 days post surgery, significantly longer than those with no HOS (12 days). The protocol was applied to the majority of EHOS patients and achieved 100 % effectiveness. 50 % of readmissions were due to altered electrolyte balance. Hypomagnesaemia was observed in 33 % of the late HOS patients. The protocol developed at our hospital for the detection and management of HOS effectively addresses possible long-term complications arising from poor nutritional status and chronic electrolyte alteration.


  • Recalcitrant warts and topical cidofovir: predictive factors of good response

    by L. Padilla España, J. del Boz, T. Fernández‐Morano, I. Escudero‐Santos, J. Arenas‐Villafranca, M. de Troya


  • PS-074 Omission or overprescription of drugs during hospital reconciliation caused by errors in the information sources

    by Jj Arenas Villafranca, M Nieto Guindo, R Romero Domínguez, Me Blanco Rivas, E Álvaro Sanz, R Quirós López

    Background Hospital/home treatment reconciliation often finds a lack of concordance between how patients take their medicines and how they should take them. Purpose To reveal which drugs patients take and are not included in our clinical information sources (medical income report and electronic primary care history) and which drugs patients do not take but are recorded in these sources. All of them were detected by a pharmacist-patient interview. Material and methods For two months a hospital pharmacist carried out treatment reconciliation at admission. Home treatment information from the two clinical information sources was recorded, and then a medicines interview was conducted. A report was written reflecting the real use of medicines in every case. All omitted or overprescribed drugs were recorded for statistical analysis. Results 23 patients were interviewed, 73.6 ± 11.6 years, with a median of 9 drugs in their home treatment (range 5 to 20), 63.6% women. We found that 25.9% of patients had medicine (s) omitted from their medical admission reports, and 17.8% from their electronic primary care history. A total of 83 drugs were omitted in the physician admission reports. These included some high-risk drugs: 3 patients taking digoxin, 3 antiplatelet drugs and 2 anticoagulants. 36 drugs were omitted in the primary care electronic clinical history, including 2 omissions of anticoagulants and 2 antiplatelet agents. Regarding medicines that the patient did not take but were stated in the information sources: the physician admission report overprescribed 30 drugs, including 1 antiplatelet drug, 1 antipsychotic and 1 antidepressant (high-risk drugs). With respect to the electronic clinical history, 24 drugs were overprescribed, including the high-risk drugs 1 antiplatelet drug, 2 antipsychotics and 2 antidepressants. Conclusion The quality of the data provided by the information sources is not sufficient, creating a risk of drugs omission or over-prescription. Hospital pharmacists could contribute positively to medicines reconciliation at admission. Reference Galvin M, Jago-Byrne MC, Fitzsimons M, et al. Clinical pharmacist’s contribution to medication reconciliation on admission to hospital in Ireland. Int J Clin Pharm 2013;35:14–21 ReferenceNo conflict of interest.